Recent BIIB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2024 09:23:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:39:18 PM
- Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference • GlobeNewswire Inc. • 10/30/2024 11:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:45:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2024 08:31:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 10:55:17 AM
- US Futures Rise as Tech Earnings Drive Market Optimism; Oil Prices Edge Up • IH Market News • 10/30/2024 10:37:30 AM
- Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases • GlobeNewswire Inc. • 10/29/2024 10:00:23 PM
- Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer • GlobeNewswire Inc. • 10/29/2024 12:00:00 PM
- Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 • GlobeNewswire Inc. • 10/28/2024 12:30:00 PM
- Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 • GlobeNewswire Inc. • 10/27/2024 12:15:00 AM
- Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference • GlobeNewswire Inc. • 10/24/2024 11:30:00 AM
- Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 • GlobeNewswire Inc. • 10/22/2024 11:30:00 AM
- Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients • GlobeNewswire Inc. • 10/09/2024 11:30:00 AM
- New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA • GlobeNewswire Inc. • 10/08/2024 11:30:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/07/2024 11:08:27 PM
- UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024 • GlobeNewswire Inc. • 09/24/2024 05:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 11:31:32 AM
- Biogen Board Appoints Two New Independent Directors • GlobeNewswire Inc. • 09/12/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 10:00:08 AM
- Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA • GlobeNewswire Inc. • 09/04/2024 11:30:34 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2024 05:00:40 PM
- Leqembi® (lecanemab) Authorized for Early Alzheimer's Disease in Great Britain • PR Newswire (US) • 08/22/2024 09:10:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/16/2024 10:40:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:30:57 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM